Kevin Du, MD, PhD, MSCI
Associate Professor of Therapeutic RadiologyCards
About
Research
Publications
2026
Curietherapy User eXperience pilot study (CurieUx): a feasibility study of a novel augmented reality educational tool during radiation oncology consultation for patients with breast cancer
Byun D, Liu E, Maisonet O, Xiao J, Du K, Gerber N. Curietherapy User eXperience pilot study (CurieUx): a feasibility study of a novel augmented reality educational tool during radiation oncology consultation for patients with breast cancer. International Journal Of Radiation Oncology • Biology • Physics 2026 PMID: 41539575, DOI: 10.1016/j.ijrobp.2025.12.057.Peer-Reviewed Original ResearchRadiation oncology consultationOncology consultationBurden of cancer treatmentPsychological burdenBreast cancerRadiation knowledgeEducational toolPilot qualitative studyLikert scale surveySemistructured interviewsQualitative studyFeasibility studyPatient anxietyPositive experiencesConsultationPilot studyScale surveyAnxietyProof-of-concept studyBreastConsultation practiceTreatment machinePatient-specific anatomyComponents of anxietyMultiple domains
2025
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study
Cohen D, Goldberg J, Leichman L, Hochman T, Newman E, Du K, Megibow A, Oberstein P, Al-Rajabi R, Scott A, Bekaii-Saab T, Messersmith W, Weekes C. Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study. The Oncologist 2025, 30: oyaf271. PMID: 40972532, PMCID: PMC12526980, DOI: 10.1093/oncolo/oyaf271.Peer-Reviewed Original ResearchBR-PDAC patientsStereotactic body radiotherapyBR-PDACR-PDACNeoadjuvant therapyR0 resectionSurgical resectionOverall survivalResection rateSingle arm phase 2 studyBorderline resectable pancreatic adenocarcinomaBorderline resectable PDACLocalized Pancreatic CancerResectable pancreatic adenocarcinomaSurgical resection rateR0 resection rateResidual microscopic diseasePhase 2 studyMedian OSGemcitabine/nab-paclitaxelPerioperative therapyResectable PDACMicroscopic diseaseOptimal regimenPrimary endpoint
2023
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848
Tchelebi L, Winter K, Abrams R, Safran H, Regine W, McNulty S, Wu A, Du K, Seaward S, Bian S, Aljumaily R, Shivnani A, Knoble J, Crocenzi T, DiPetrillo T, Roof K, Crane C, Goodman K. Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848. International Journal Of Radiation Oncology • Biology • Physics 2023, 118: 107-114. PMID: 37598723, PMCID: PMC10843017, DOI: 10.1016/j.ijrobp.2023.08.014.Peer-Reviewed Original ResearchConceptsTarget volumeRadiation therapy quality assuranceRadiation therapyPlanning target volumeClinical treatment volumeGross target volumePretreatment QAContouring atlasTreatment planningResectable pancreatic head adenocarcinomaRT planningIntensity modulated RTQA analysisPancreatic head adenocarcinomaNRG Oncology RTOGPracticing radiation oncologistsReal-time quality assuranceTreatment volumeEffects of RTConcurrent fluoropyrimidineConformal RTAdjuvant chemotherapyRadiation oncologistsQuality assurancePancreas cancerMilestones 2.0: Refining the Competency-Based Assessment of Radiation Oncology Medical Residents
Thomas H, Braunstein S, Golden D, Du K, Weiner A, Bridges K, Vijayakumar S, McLean S, Edgar L, Fields E. Milestones 2.0: Refining the Competency-Based Assessment of Radiation Oncology Medical Residents. International Journal Of Radiation Oncology • Biology • Physics 2023, 115: 12-18. PMID: 36526379, DOI: 10.1016/j.ijrobp.2022.07.1838.Commentaries, Editorials and Letters
2021
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.
Tchelebi L, Winter K, Abrams RA, Safran H, Regine WF, McNulty S, Wu AJ, Du KL, Seaward SA, Bian SX, Aljumaily R, Shivnani AT, Moore T, Crocenzi T, DiPetrillo TA, Kuykendal A, Crane CH, Goodman KA. Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848. International Journal Of Radiation Oncology, Biology, Physics 2021, 111: S40. PMID: 34700550, DOI: 10.1016/j.ijrobp.2021.07.114.Peer-Reviewed Original ResearchInterprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional Experience
Padilla L, Burmeister JW, Burnett OL, Covington EL, Den RB, Dominello MM, Du KL, Galavis PE, Junell S, Kahn J, Kishore M, Mooney K, Mukhopadhyay ND, Studenski MT, Yechieli RL, Fields EC. Interprofessional Image Verification Workshop for Physician and Physics Residents: A Multi-Institutional Experience. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: 1058-1065. PMID: 34380009, DOI: 10.1016/j.ijrobp.2021.07.1706.Peer-Reviewed Original ResearchBreaking Tradition to Bridge Bench and Bedside: Accelerating the MD-PhD-Residency Pathway.
Modrek AS, Tanese N, Placantonakis DG, Sulman EP, Rivera R, Du KL, Gerber NK, David G, Chesler M, Philips MR, Cangiarella J. Breaking Tradition to Bridge Bench and Bedside: Accelerating the MD-PhD-Residency Pathway. Academic Medicine 2021, 96: 518-521. PMID: 33464738, DOI: 10.1097/acm.0000000000003920.Peer-Reviewed Original Research
2018
Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis
Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Myint A, Smith FM, Saunders MP, Scott N, O'Dwyer ST, de Castro Araujo RO, Valadao M, Lopes A, Hsiao CW, Lai CL, Smith RK, Paulson EC, Appelt A, Jakobsen A, Wexner SD, Habr-Gama A, Julião G, Perez R, Renehan AG. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. The Lancet Gastroenterology & Hepatology 2018, 3: 825-836. PMID: 30318451, DOI: 10.1016/s2468-1253(18)30301-7.Peer-Reviewed Original ResearchConceptsClinical complete responseIndividual participant dataComplete responseLocal regrowthRectal cancerCumulative incidenceParticipant dataNeoadjuvant chemoradiotherapyHazard ratioSustained clinical complete responseProportion of patientsCenter heterogeneityRecent systematic reviewCox frailty modelStage cT1CT2 tumorsMajor surgeryPrimary outcomeTreatment characteristicsChemoradiotherapyLower riskPatientsStudy heterogeneitySystematic reviewNovel management strategiesObjective Evaluation of a Didactic Curriculum for the Radiation Oncology Medical Student Clerkship
Golden D, Kauffmann G, McKillip R, Farnan J, Park Y, Schwartz A, Group R, Hirsch A, Warren L, Spektor A, Rudra S, Jimenez R, Colbert L, Gunther J, Das P, Wu A, Du K, Kruser T, Nabavizadeh N, Thomas C, Hara W, McDonald A, Chang E, Braunstein S, Chmura S, Amsbaugh M, Yechieli R, Takita C, Dean M, Asher D, Taunk N, Vargo J, Beriwal S, Ye J, Ballas L, Ballo M, Brower J, Bradley K, Rao Y, Stahl J, Higgins S. Objective Evaluation of a Didactic Curriculum for the Radiation Oncology Medical Student Clerkship. International Journal Of Radiation Oncology • Biology • Physics 2018, 101: 1039-1045. PMID: 29908787, PMCID: PMC6538302, DOI: 10.1016/j.ijrobp.2018.04.052.Peer-Reviewed Original ResearchConceptsRadiation Oncology Education Collaborative Study GroupRadiation oncology clerkshipsRadiation Oncology Education Collaborative Study Group curriculumAcademic medical centerKnowledge assessmentMedical CenterPost-curriculumMultiple academic medical centersAssessment scoresMedical student clerkshipDidactic curriculumLate time pointsCollaborative Study GroupMean assessment scoreStudy groupCurriculum efficacyMedical studentsEducational approachCurriculum exposureCurriculumStudentsStudent clerkshipTime pointsPost-scoresPre-scoresDosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer
Wang H, Du K, Qu J, Chandarana H, Das IJ. Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer. PLOS ONE 2018, 13: e0190883. PMID: 29304105, PMCID: PMC5755922, DOI: 10.1371/journal.pone.0190883.Peer-Reviewed Original Research
Clinical Trials
Current Trials
A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features
IRB ID2000031055RoleSub InvestigatorPrimary Completion Date02/28/2026Recruiting Participants
Academic Achievements & Community Involvement
Clinical Care
Overview
Kevin Du, MD, PhD, is a radiation oncologist who specializes in therapeutic radiology, with a focus on breast cancer and gastrointestinal radiotherapy. He is dedicated to improving cancer care through innovative treatment approaches, including organ preservation techniques and clinical trials aimed at enhancing patient quality of life.
Dr. Du believes in tailoring cancer treatments to meet the individual needs of his patients, leveraging cutting-edge biology and technology. He expresses a strong commitment to his patients, saying, "the incredible opportunity to learn about my patients' lives, what is important to them, and to help them in a time of crisis," is his favorite part of the job.
Dr. Du is an associate professor at Yale School of Medicine, where his work emphasizes the importance of clinical trials in developing new cancer therapies, particularly for challenging conditions like stomach cancer.
“While I can’t guarantee what will happen in the long run, I can guarantee that I will give you the best care possible, and that I will help you in any way I can,” he says.
Dr. Du completed his medical training and doctoral degree at the University of Pennsylvania and a residency in radiation oncology at the Hospital of the University of Pennsylvania.
Clinical Specialties
Gastrointestinal Radiotherapy; Breast Cancer Radiotherapy; Therapeutic Radiology
Fact Sheets
Gastrointestinal Cancers
Learn More on Yale MedicineProstate Cancer
Learn More on Yale MedicineBreast Cancer
Learn More on Yale MedicineSmall Intestine Adenocarcinoma
Learn More on Yale Medicine
Yale Medicine News
News & Links
Media
Center for GI Cancers CME Series: Colorectal Liver Metastases
Moderated by Jeremy Kortmansky, MD
Presenters:
Sajid Khan, MD
Kevin Du, MD, PhD
David Madoff, MD
Gastroesophageal Cancer: Life Beyond Treatment - Healing, Hope & Health
April 30, 2026
Hosted by: Drs. Raghav Sundar and Pamela Kunz
Presentations by:
Kevin Du, MD, PhD, MSCI
Scott Capozza, PT, MS
Natalie Smith, RDN, CSO
Daniel Boffa, MD
Derek Yach, MD
Deepika Karki, MBBS
News
- March 24, 2026
AI in Cancer Workshop: Advancing Precision Medicine through Interdisciplinary Innovation
- March 20, 2026
Center for GI Cancers CME Series: Colorectal Liver Metastases
- October 06, 2025
Yale Cancer Center Researchers and Trainees Present at 2025 ASTRO Annual Meeting
- May 12, 2025
Smilow Cancer Hospital Gastrointestinal Oncology Expertise in Fairfield County
Get In Touch
Contacts
Appointment Number
Office Fax Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.